Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Personalis Inc
(NQ:
PSNL
)
3.955
+0.025 (+0.64%)
Streaming Delayed Price
Updated: 11:52 AM EST, Nov 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Personalis Inc
< Previous
1
2
3
4
5
6
7
Next >
Personalis Reports Fourth Quarter and Full Year 2021 Financial Results
February 24, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis to Present at the Cowen 42nd Annual Health Care Conference
February 23, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Collaboration with UC San Diego Moores Cancer Center for Clinical Genomic Testing and Research into Composite Biomarkers and Minimal Residual Disease Detection
February 15, 2022
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Fourth Quarter and Full-Year Financial Results
February 10, 2022
From
Personalis, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
January 18, 2022
Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...
Via
Benzinga
Personalis to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 01, 2022
From
Personalis, Inc.
Via
Business Wire
56 Biggest Movers From Friday
January 10, 2022
Gainers Hour Loop, Inc. (NASDAQ: HOUR) shares jumped 99.8% to $7.99 after the company priced its IPO at $4 per share. China HGS Real Estate Inc. (NASDAQ: HGSH) shares...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 19, 2022
During Wednesday's morning trading, 400 companies set new 52-week lows. 52-Week Low Highlights: Intuitive Surgical (NASDAQ:ISRG) was the largest company by...
Via
Benzinga
33 Stocks Moving In Friday's Mid-Day Session
January 07, 2022
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 35.9% to $4.6899 after the company announced an integration with Amazon Ads' demand-side platform. Absci...
Via
Benzinga
Personalis Reports Preliminary Fourth Quarter and Full Year 2021 Revenue
January 06, 2022
From
Personalis, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 05, 2022
Gainers SomaLogic (NASDAQ:SLGC) shares mo...
Via
Benzinga
Personalis to Participate in the 24th Annual Needham Virtual Growth Conference
December 28, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Launches NeXT Personal™, A Tumor-Informed Liquid Biopsy Assay for MRD and Recurrence Detection With Part-Per-Million Sensitivity
December 16, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference
November 18, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Named to Inc.'s 2021 Best-Led Companies List
November 12, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Present New Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
November 11, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis's Return On Capital Employed Insights
November 08, 2021
Benzinga Pro data, Personalis (NASDAQ:PSNL) reported Q3 sales of $22.26 million. Earnings fell to a loss of $17.69 million, resulting in a 18.36% decrease from last quarter....
Via
Benzinga
Personalis Reports Third Quarter 2021 Financial Results
November 04, 2021
From
Personalis, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021
November 03, 2021
Upgrades Benchmark upgraded the previous rating for Devon Energy Corp (NYSE:
Via
Benzinga
Personalis Announces Updates to NeXT Platform™ Incorporating Additional Key Profiling Capabilities for Advancing Oncology Biomarkers
November 02, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Issuance of US Patents Related to the Exome-Wide NeXT Liquid Biopsy Platform
October 26, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis Publishes New Data Demonstrating Performance and Utility of SHERPA for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development
October 26, 2021
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Third Quarter Financial Results on November 4, 2021
October 21, 2021
From
Personalis, Inc.
Via
Business Wire
Notable Personalis Insider Makes $1.9M Sale
October 15, 2021
Stephen John West, President And CEO at Personalis (NASDAQ:PSNL), made a large insider sell on October 12, according to a new SEC filing. What Happened: A Form 4 filing from the...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Personalis Expands Leadership Team With Appointment of Robert Bruce, Vice President of Reimbursement
October 13, 2021
From
Personalis, Inc.
Via
Business Wire
Mayo Clinic Collaborates With Personalis Inc. to Expand Cancer Genomic Testing
October 12, 2021
From
Personalis Inc.
Via
Business Wire
Cathie Wood Goes Bargain Shopping: 3 Sinking Stocks She Keeps Buying
September 20, 2021
The CEO of ARK Invest is averaging down on these compelling life-science stocks.
Via
The Motley Fool
Personalis Receives New VA MVP Task Order and Record Quarterly Orders From Oncology Customers; Reconfirms Total Revenue Outlook for 2021 with Further Accelerated Oncology Growth
September 18, 2021
From
Personalis, Inc.
Via
Business Wire
Cathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just Bought
September 09, 2021
All of these stocks are more than 40% below their peaks, but at least one important investor thinks they can recover.
Via
The Motley Fool
Personalis to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference
August 26, 2021
From
Personalis, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.